Diez-Cirarda, Maria https://orcid.org/0000-0001-6768-189X
Cabrera-Zubizarreta, Alberto
Murueta-Goyena, Ane
Strafella, Antonio P.
Del Pino, Rocio
Acera, Marian
Lucas-Jiménez, Olaia
Ibarretxe-Bilbao, Naroa
Tijero, Beatriz
Gómez-Esteban, Juan Carlos
Gabilondo, Iñigo https://orcid.org/0000-0001-6045-2840
Funding for this research was provided by:
Osasun Saila, Eusko Jaurlaritzako (The Department of Health of the Basque Government through Project 2016111009)
Osasun Saila, Eusko Jaurlaritzako (The Department of Health of the Basque Government through Project 2016111009)
Osasun Saila, Eusko Jaurlaritzako (Post-doctoral research improvement fellowship [POS_2018_1_0008])
Article History
Received: 21 July 2022
Revised: 13 October 2022
Accepted: 14 October 2022
First Online: 8 November 2022
Change Date: 6 December 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00415-022-11492-2
Declarations
:
: A.P.S. has been a consultant for Hoffman La Roche; received honoraria from GE Health Care Canada LTD, Hoffman La Roche. The rest of the authors declare no conflict of interest.
: The present study was approved by the Euskadi Drug Research Ethics Committee (CEIm-E) (Approval number: PI2012154) and participants provided written informed consent prior to research participation.